A client is starting therapy with bicalutamide. Which of the following adverse effects should the nurse instruct the client to monitor?

Questions 121

ATI RN

ATI RN Test Bank

ATI Pharmacology Questions

Question 1 of 5

A client is starting therapy with bicalutamide. Which of the following adverse effects should the nurse instruct the client to monitor?

Correct Answer: C

Rationale: In this scenario, the correct answer is C) Gynecomastia. Bicalutamide is an androgen receptor antagonist commonly used in the treatment of prostate cancer. Gynecomastia, the development of breast tissue in males, is a well-known adverse effect of bicalutamide due to its anti-androgenic properties. It is crucial for the nurse to educate the client on monitoring for signs of gynecomastia to ensure early detection and intervention. Muscle pain (option A) is not typically associated with bicalutamide use and is therefore not a priority adverse effect to monitor. Flushing (option B) is also not a common side effect of bicalutamide and is unlikely to occur. Hyperglycemia (option D) is not directly related to bicalutamide use and is more commonly associated with other medications or conditions. In an educational context, understanding the adverse effects of medications is essential for nurses to provide safe and effective care to their clients. By knowing the expected side effects of specific drugs, nurses can educate clients on what to monitor for and when to seek medical attention. This knowledge enhances patient safety and promotes better outcomes in pharmacological therapy.

Question 2 of 5

A client is receiving treatment with irinotecan. Which of the following findings should the nurse monitor?

Correct Answer: A

Rationale: In the context of a client receiving treatment with irinotecan, monitoring for diarrhea is crucial due to the common side effect of irinotecan-induced severe diarrhea. This adverse effect can lead to dehydration, electrolyte imbalances, and potential complications if not managed promptly. Therefore, Option A, diarrhea, is the correct answer that the nurse should monitor. Hypertension (Option B) is not a typical side effect associated with irinotecan therapy. Ototoxicity (Option C) is more commonly linked to certain antibiotics and chemotherapeutic agents like cisplatin, not irinotecan. Neutropenia (Option D) is a potential side effect of many chemotherapy drugs, but it is not specifically associated with irinotecan. Educationally, understanding the side effects of specific medications is crucial for nurses to provide safe and effective care to their patients. Monitoring for and recognizing common adverse effects of chemotherapy drugs like irinotecan can help prevent complications and improve patient outcomes. Nurses need to be knowledgeable about the expected side effects of medications to provide comprehensive care and timely interventions.

Question 3 of 5

A client is starting therapy with cisplatin, and a healthcare provider is providing education. Which of the following findings should the healthcare provider instruct the client to report?

Correct Answer: A

Rationale: The correct answer is A: Tinnitus. The healthcare provider should instruct the client to report tinnitus, as it can be an indication of ototoxicity, an adverse effect associated with cisplatin therapy. Ototoxicity is damage to the inner ear structures that can lead to hearing loss, making it crucial for the client to report any early signs such as tinnitus to prevent further complications.

Question 4 of 5

A client has a new prescription for Digoxin. Which of the following findings should the nurse identify as a potential sign of Digoxin toxicity?

Correct Answer: A

Rationale: In this scenario, the correct answer is A) Nausea, as a potential sign of Digoxin toxicity. Digoxin is a medication commonly used to treat heart conditions like heart failure and atrial fibrillation. It works by increasing the force of the heart's contractions. However, an overdose or toxicity of Digoxin can lead to various adverse effects, including gastrointestinal symptoms like nausea and vomiting. Option B) Dry mouth is not typically associated with Digoxin toxicity. Dry mouth is a common side effect of various medications, but it is not a specific indicator of Digoxin toxicity. Option C) Hypoglycemia is not a typical sign of Digoxin toxicity. While Digoxin toxicity can lead to changes in electrolyte levels, hypoglycemia is not a direct effect of Digoxin toxicity. Option D) Tinnitus is a classic sign of Digoxin toxicity. Tinnitus, along with visual disturbances like blurred or yellow vision, are common neurological manifestations of Digoxin toxicity. Educationally, understanding the signs and symptoms of Digoxin toxicity is crucial for nurses and healthcare professionals to provide safe and effective care to patients taking this medication. Recognition of these signs can prompt timely interventions to prevent serious complications associated with Digoxin toxicity.

Question 5 of 5

A healthcare provider is providing discharge instructions to a client who is prescribed Prednisone. Which of the following dietary instructions should the healthcare provider include?

Correct Answer: A

Rationale: Prednisone can cause potassium depletion, so clients should increase their intake of potassium-rich foods such as bananas, oranges, and spinach. Potassium-rich foods help maintain electrolyte balance and prevent complications associated with low potassium levels, such as muscle weakness and irregular heartbeats.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions